Rezension:
Lost credit card metronidazole cream generic available This withdrawal decision follows talks with the U.S. Food and Drug Administration or FDA on its proposed process for the review of interim data. Sanofi believes that potential public disclosure of early interim data, even with safeguards, could potentially compromise the integrity of the ongoing ELIXA trial. Sanofi said it\'s decision is unrelated to safety issues or deficiencies in the NDA.
